1465 related articles for article (PubMed ID: 19368079)
1. Present and potential future adjuvant issues in high-grade astrocytic glioma treatment.
Lefranc F; Rynkowski M; DeWitte O; Kiss R
Adv Tech Stand Neurosurg; 2009; 34():3-35. PubMed ID: 19368079
[TBL] [Abstract][Full Text] [Related]
2. [The sodium pump could constitute a new target to combat glioblastomas].
Lefranc F; Mijatovic T; Kiss R
Bull Cancer; 2008 Mar; 95(3):271-81. PubMed ID: 18390407
[TBL] [Abstract][Full Text] [Related]
3. [Glioblastomas are resistant to apoptosis but less resistant to the autophagic process].
Lefranc F
Bull Mem Acad R Med Belg; 2007; 162(5-6):331-8. PubMed ID: 18405003
[TBL] [Abstract][Full Text] [Related]
4. Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistance.
McCubrey JA; Steelman LS; Abrams SL; Lee JT; Chang F; Bertrand FE; Navolanic PM; Terrian DM; Franklin RA; D'Assoro AB; Salisbury JL; Mazzarino MC; Stivala F; Libra M
Adv Enzyme Regul; 2006; 46():249-79. PubMed ID: 16854453
[TBL] [Abstract][Full Text] [Related]
5. Embryonic stem cell (ESC)-mediated transgene delivery induces growth suppression, apoptosis and radiosensitization, and overcomes temozolomide resistance in malignant gliomas.
Germano IM; Emdad L; Qadeer ZA; Binello E; Uzzaman M
Cancer Gene Ther; 2010 Sep; 17(9):664-74. PubMed ID: 20523363
[TBL] [Abstract][Full Text] [Related]
6. Editorial: on the road to multi-modal and pluri-disciplinary treatment of glioblastomas.
Lefranc F
Acta Neurochir (Wien); 2009 Feb; 151(2):109-12. PubMed ID: 19194651
[TBL] [Abstract][Full Text] [Related]
7. The role of autophagy in sensitizing malignant glioma cells to radiation therapy.
Zhuang W; Qin Z; Liang Z
Acta Biochim Biophys Sin (Shanghai); 2009 May; 41(5):341-51. PubMed ID: 19430698
[TBL] [Abstract][Full Text] [Related]
8. Proautophagic drugs: a novel means to combat apoptosis-resistant cancers, with a special emphasis on glioblastomas.
Lefranc F; Facchini V; Kiss R
Oncologist; 2007 Dec; 12(12):1395-403. PubMed ID: 18165616
[TBL] [Abstract][Full Text] [Related]
9. Possible future issues in the treatment of glioblastomas: special emphasis on cell migration and the resistance of migrating glioblastoma cells to apoptosis.
Lefranc F; Brotchi J; Kiss R
J Clin Oncol; 2005 Apr; 23(10):2411-22. PubMed ID: 15800333
[TBL] [Abstract][Full Text] [Related]
10. Suppression of RAF/MEK or PI3K synergizes cytotoxicity of receptor tyrosine kinase inhibitors in glioma tumor-initiating cells.
Shingu T; Holmes L; Henry V; Wang Q; Latha K; Gururaj AE; Gibson LA; Doucette T; Lang FF; Rao G; Yuan L; Sulman EP; Farrell NP; Priebe W; Hess KR; Wang YA; Hu J; Bögler O
J Transl Med; 2016 Feb; 14():46. PubMed ID: 26861698
[TBL] [Abstract][Full Text] [Related]
11. Pro-apoptotic and pro-autophagic effects of the Aurora kinase A inhibitor alisertib (MLN8237) on human osteosarcoma U-2 OS and MG-63 cells through the activation of mitochondria-mediated pathway and inhibition of p38 MAPK/PI3K/Akt/mTOR signaling pathway.
Niu NK; Wang ZL; Pan ST; Ding HQ; Au GH; He ZX; Zhou ZW; Xiao G; Yang YX; Zhang X; Yang T; Chen XW; Qiu JX; Zhou SF
Drug Des Devel Ther; 2015; 9():1555-84. PubMed ID: 25792811
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic exploitation of apoptosis and autophagy for glioblastoma.
Kögel D; Fulda S; Mittelbronn M
Anticancer Agents Med Chem; 2010 Jul; 10(6):438-49. PubMed ID: 20879985
[TBL] [Abstract][Full Text] [Related]
13. Paediatric high and low grade glioma: the impact of tumour biology on current and future therapy.
Hargrave D
Br J Neurosurg; 2009 Aug; 23(4):351-63. PubMed ID: 19637006
[TBL] [Abstract][Full Text] [Related]
14. ROS-dependent activation of autophagy is a critical mechanism for the induction of anti-glioma effect of sanguinarine.
Pallichankandy S; Rahman A; Thayyullathil F; Galadari S
Free Radic Biol Med; 2015 Dec; 89():708-20. PubMed ID: 26472194
[TBL] [Abstract][Full Text] [Related]
15. Evidence of galectin-1 involvement in glioma chemoresistance.
Le Mercier M; Lefranc F; Mijatovic T; Debeir O; Haibe-Kains B; Bontempi G; Decaestecker C; Kiss R; Mathieu V
Toxicol Appl Pharmacol; 2008 Jun; 229(2):172-83. PubMed ID: 18313712
[TBL] [Abstract][Full Text] [Related]
16. Autophagy, the Trojan horse to combat glioblastomas.
Lefranc F; Kiss R
Neurosurg Focus; 2006 Apr; 20(4):E7. PubMed ID: 16709038
[TBL] [Abstract][Full Text] [Related]
17. Molecularly targeted therapy for malignant glioma.
Sathornsumetee S; Reardon DA; Desjardins A; Quinn JA; Vredenburgh JJ; Rich JN
Cancer; 2007 Jul; 110(1):13-24. PubMed ID: 17520692
[TBL] [Abstract][Full Text] [Related]
18. Is there a common upstream link for autophagic and apoptotic cell death in human high-grade gliomas?
Emdad L; Qadeer ZA; Bederson LB; Kothari HP; Uzzaman M; Germano IM
Neuro Oncol; 2011 Jul; 13(7):725-35. PubMed ID: 21727211
[TBL] [Abstract][Full Text] [Related]
19. Autophagic and Apoptotic Pathways as Targets for Chemotherapy in Glioblastoma.
Trejo-Solís C; Serrano-Garcia N; Escamilla-Ramírez Á; Castillo-Rodríguez RA; Jimenez-Farfan D; Palencia G; Calvillo M; Alvarez-Lemus MA; Flores-Nájera A; Cruz-Salgado A; Sotelo J
Int J Mol Sci; 2018 Nov; 19(12):. PubMed ID: 30486451
[TBL] [Abstract][Full Text] [Related]
20. The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.
Garside R; Pitt M; Anderson R; Rogers G; Dyer M; Mealing S; Somerville M; Price A; Stein K
Health Technol Assess; 2007 Nov; 11(45):iii-iv, ix-221. PubMed ID: 17999840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
